From hero to zero: a fair-value nightmare(2)

It’s the spectre now haunting the private equity industry: Under what scenario might the value of an otherwise healthy LBO deal be written down to zero? David Snow presents some maths that many GPs are hoping to avoid.

North AmericaCommentary